BMW’s iNext electric, self-driving flagship car set to hit showrooms in 2021
During the course of bigwig automaker BMW's annual shareholders meeting in Munich on Thursday, CEO Harald Krueger revealed that the company is readying its iNext electric, self-driving flagship car.
According to the details shared by Krueger, the iNext electric, self-driving car is scheduled to hit showrooms in the year 2021.
The imminent availability of the BMW iNext in 2021 will mark a new addition to the luxury car manufacturer's 'i' sub-brand, which presently includes the company's i3 electric vehicle and i8 plug-in hybrid.
Krueger has revealed that the iNext electric, self-driving car will boast a new interior, along with an avant-garde electric powertrain. The car will essentially be one of the key focus areas in BMW's attempts to retain its dominance in the luxury-car arena, especially against challengers like Tesla Motors.
To highlight the significance of iNext electric, self-driving car for BMW, Kueger said in his prepared comments at shareholders meeting that iNext will be BMW's "new innovation driver, with autonomous driving, digital connectivity, intelligent lightweight design, a totally new interior and ultimately bringing the next generation of electro-mobility to the road."
American aviation major Boeing has signaled its intent to unveil a modified version of its 737 MAX 10 aircraft at the opening of the Paris Airshow on Monday this week.
The odd dual-screen device called the YotaPhone 3 has been officially announced in the East Asian country of China for 2017 release.
After successfully launching its first X-ray space telescope, China is now preparing to launch four more space probes before 2021 as part of the ongoing efforts to develop space science.
The European Union (EU) is reportedly preparing to impose a record-high fine on tech giant Google (Alphabet) within the next few weeks, according to a WSJ report.
The U.S. Food & Drug Administration (FDA) has finally approved a new epinephrine injector for anaphylaxis, increasing competition for the controversially expensive injector EpiPen.
CenturyLink stock suffered major setback after Bloomberg published a report citing a former CenturyLink employee claiming that she was fired after she reported about fraud billing practices in the company.